Hm Payson & CO Pacira Bio Sciences, Inc. Transaction History

Hm Payson & CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $10,298 - $16,328	-200 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$60.03 - $76.49 $27,013 - $34,420	-450 Reduced 69.23%	200 $15,000
Q4 2021 Feb 15, 2022	SELL	$47.97 - $62.21 $28,782 - $37,326	-600 Reduced 48.0%	650 $39,000
Q2 2021 Aug 17, 2021	BUY	$59.18 - $69.99 $71,016 - $83,988	1,200 Added 2400.0%	1,250 $76,000
Q1 2021 Jun 15, 2021	BUY	$59.31 - $78.82 $2,965 - $3,940	50 New	50 $4,000
Q2 2020 Aug 13, 2020	SELL	$30.8 - $52.47 $9,240 - $15,741	-300 Closed	0 $0
Q1 2020 Jul 01, 2020	SELL	$28.4 - $50.7 $5,680 - $10,140	-200 Reduced 40.0%	300 $10,000
Q3 2019 Nov 12, 2019	SELL	$35.66 - $44.99 $14,263 - $17,996	-400 Reduced 44.44%	500 $19,000
Q2 2019 Aug 15, 2019	BUY	$36.57 - $47.97 $32,913 - $43,173	900 New	900 $39,000

260

49.8M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.15B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.